增生性瘢痕血流、微血管与红斑评估:横断面研究提示需精准定义
该横断面研究纳入32例成年增生性瘢痕切除患者,术前用激光多普勒成像测血流、色度计测红斑、POSAS主观评估发红,术后免疫组化测微血管。仅红斑与主观发红相关(r=0.403,p=0.030),血流、微血管与红斑间无相关性,提示这些是不同特征,术语不可互换。
要点
- 增生性瘢痕的血流、微血管存在与红斑是不同特征,不可互换术语。
- 仅色度计红斑与POSAS主观发红呈中度相关(r=0.403,p=0.030)。
- 「血管化」不宜作为统称,研究与临床应使用精准定义。
核心结论
- 血流、微血管存在和红斑是增生性瘢痕的不同特征,因缺乏相关性而不能互换术语。
- 「血管化」不适合作为统称,建议在研究和临床中使用精准定义。
研究设计与样本
- 横断面研究,纳入32例年龄≥18岁、接受择期增生性瘢痕切除的连续患者。
- 术前在预定约1.5cm感兴趣区内行激光多普勒成像、色度计和POSAS评估,术后对感兴趣区行免疫组化测微血管。
主要发现
- 色度计红斑值与POSAS主观发红评估呈统计学显著相关(r=0.403,p=0.030)。
- 激光多普勒成像、免疫组化和色度计的结果之间未发现相关性。
临床怎么用
- 临床评估增生性瘢痕时,应区分血流、微血管存在和红斑,避免混用术语。
- 研究和临床记录中建议采用精准定义,而非以「血管化」笼统替代。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In hypertrophic scar assessment, laser Doppler imaging (LDI), colorimetry and subjective assessment (POSAS) can be used to evaluate blood flow, erythema and redness, respectively. In addition, the microvasculature (i.e. presence of microvessels) can be determined by immunohistochemistry. These measurement techniques are frequently used in clinical practice and/or in research to evaluate treatment response and monitor scar development. However, until now it has not been tested to what extent the outcomes of these techniques are associated, whilst the outcome terms are frequently used interchangeably or replaced by the umbrella term 'vascularization'. This is confusing, as every technique seems to measure a specific feature. Therefore, we evaluated the correlations of the four measurement techniques. METHODS: We included 32 consecutive patients, aged ≥18 years, who underwent elective resection of a hypertrophic scar. Pre-operatively, we performed LDI (measuring blood flow), colorimetry (measuring erythema) and the POSAS (subjective redness) within the predefined scar area of interest (∼1.5cm). Subsequently, the scar was excised and the area of interest was sent for immunohistochemistry, to determine the presence of microvessels. RESULTS: Only a statistically significant correlation was found between erythema values (colorimetry) and subjective redness assessment (POSAS) (r=0.403, p=0.030). We found no correlations between the outcomes of LDI, immunohistochemistry and colorimetry. CONCLUSIONS: Blood flow, the presence of microvessels and erythema appear to be different hypertrophic scar features because they show an absence of correlation. Therefore, in the field of scar assessment, these outcome terms cannot be used interchangeably. In addition, we conclude that the term 'vascularization' does not seem appropriate to serve as an umbrella term. The use of precise definitions in research as well as in clinical practice is recommended.
引用
- Jaspers MEH, Stekelenburg CM, Simons JM, et al. Assessing blood flow, microvasculature, erythema and redness in hypertrophic scars: A cross sectional study showing different features that require precise definitions. Burns. 2017. PMID: 28153584. doi:10.1016/j.burns.2017.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。